Ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia: NICE technology appraisal guidance.
Charles
Z
Z
National Institute for Health and Clinical Excellence, UK.
Pugh
E
E
Barnett
D
D
D000328:Adult; D000924:Anticholesteremic Agents / Q000191:economics / Q000627:therapeutic use*; D001384:Azetidines / Q000191:economics / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D000069438:Ezetimibe; D005260:Female; D006579:Heterozygote; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D008297:Male; D017410:Practice Guidelines as Topic; D013673:Technology Assessment, Biomedical; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D001384:Azetidines; D008055:Lipids; D000069438:Ezetimibe